Introducing Quell 2.0: The Next Generation of Wearable Pain Relief Technology
As part of our mission to improve health through technology, we’re happy to introduce Quell 2.0, our latest breakthrough for the treatment of chronic pain. Taking our FDA cleared, 100% drug-free neurotechnology to a new level, Quell 2.0 is smarter, more powerful and 50% smaller than our first generation Quell.
Since first launching Quell in 2015, over 170,000 people living with chronic pain have experienced our patented neurotechnology. Our engineering and development team have integrated customer feedback along with new research and technology developments to make this the most advanced Quell ever.
Here is what you can expect from Quell 2.0:
- Design that is 50% smaller than the original device: For improved wearability and all-day comfort, Quell 2.0 is 50% smaller – with a footprint the size of a credit card or pack of gum.
- Redesigned Quell app: Based on user feedback, we’ve updated the app with an all-new easy-to-use interface and intuitive new design. The app enables users to calibrate Quell to their precise needs, start and stop therapy, chose a variety of customization and automation features, and track therapy, sleep, activity and pain.
- Smarter and more powerful: Quell 2.0 automatically adapts to changes in body position during the day and can sense when you put the device on and automatically start therapy. It’s 20% more powerful than the original device, making it the most powerful Quell yet.
We’re excited to be introducing this new device during Chronic Pain Awareness Month and at PAINWeek, the largest US scientific conference for frontline clinicians with an interest in pain management. We look forward to helping even more consumers find relief with Quell 2.0. – activating the power inside of you to relieve chronic pain and reclaim your life
Subscribe to the Living Quell Blog
Sign up for the Living Quell Blog and get the best content delivered to your inbox weekly.